---
$id: https://graph.org.ai/products/commodity/51343201
$type: Product
source: UNSPSC
code: "51343201"
title: "Raltegravir"
class: "51343200"
classTitle: "Antiviral pyrrolidinones and quinolines and thiazoles"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Raltegravir

**UNSPSC Code**: 51343201
**Class**: [Antiviral pyrrolidinones and quinolines and thiazoles](Antiviral pyrrolidinones and quinolines and thiazoles.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22VKV8053U. European Medicines Agency schedules Raltegravir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25667. Raltegravir generally arises in the molecular formula C20H21FN6O5. The term RALTEGRAVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 1, 2008, list 59.) As of Q4 2014, RALTEGRAVIR remains the US FDA Preferred Term for this commodity. Raltegravir bears US NLM identifiers UMLS ID C1871526 and NCI Concept Code C72837. SMILES: CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F.

